This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Anat Achiron, MD, PhD; Elon Pras, MD; Ronit Gilad, MD; Ilan Ziv, MD; Mathilda Mandel, MD; Carlos R. Gordon, MD, PhD; Shlomo Noy, MD; Ida Sarova-Pinhas, MD; Eldad Melamed, MD
Petah Tiqwa, Israel

Arch Neurol. 1994;51(3):234.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In reply

The article by Schuller and Govaerts,¹ has major differences compared with our study² regarding the patients treated, mode of treatment, dosage of drug used, and duration of treatment.

Schuller and Govaerts¹ have treated patients with chronic progressive multiple sclerosis (MS), and their main results are related to the disability of the patients. We have treated pa . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?